Form 8-K - Current report:
SEC Accession No. 0001558370-24-006793
Filing Date
2024-05-06
Accepted
2024-05-06 16:01:01
Documents
49
Period of Report
2024-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240506x8k.htm   iXBRL 8-K 45979
2 EX-99.1 glyc-20240506xex99d1.htm EX-99.1 28751
3 EX-99.2 glyc-20240506xex99d2.htm EX-99.2 49766
4 GRAPHIC glyc-20240506xex99d1001.jpg GRAPHIC 7094
5 GRAPHIC glyc-20240506xex99d2g001.jpg GRAPHIC 201074
6 GRAPHIC glyc-20240506xex99d2g002.jpg GRAPHIC 196550
7 GRAPHIC glyc-20240506xex99d2g003.jpg GRAPHIC 139425
8 GRAPHIC glyc-20240506xex99d2g004.jpg GRAPHIC 122617
9 GRAPHIC glyc-20240506xex99d2g005.jpg GRAPHIC 152591
10 GRAPHIC glyc-20240506xex99d2g006.jpg GRAPHIC 103560
11 GRAPHIC glyc-20240506xex99d2g007.jpg GRAPHIC 185234
12 GRAPHIC glyc-20240506xex99d2g008.jpg GRAPHIC 123506
13 GRAPHIC glyc-20240506xex99d2g009.jpg GRAPHIC 148887
14 GRAPHIC glyc-20240506xex99d2g010.jpg GRAPHIC 146761
15 GRAPHIC glyc-20240506xex99d2g011.jpg GRAPHIC 180630
16 GRAPHIC glyc-20240506xex99d2g012.jpg GRAPHIC 142767
17 GRAPHIC glyc-20240506xex99d2g013.jpg GRAPHIC 146281
18 GRAPHIC glyc-20240506xex99d2g014.jpg GRAPHIC 160952
19 GRAPHIC glyc-20240506xex99d2g015.jpg GRAPHIC 114289
20 GRAPHIC glyc-20240506xex99d2g016.jpg GRAPHIC 150916
21 GRAPHIC glyc-20240506xex99d2g017.jpg GRAPHIC 136477
22 GRAPHIC glyc-20240506xex99d2g018.jpg GRAPHIC 139747
23 GRAPHIC glyc-20240506xex99d2g019.jpg GRAPHIC 152710
24 GRAPHIC glyc-20240506xex99d2g020.jpg GRAPHIC 120818
25 GRAPHIC glyc-20240506xex99d2g021.jpg GRAPHIC 140717
26 GRAPHIC glyc-20240506xex99d2g022.jpg GRAPHIC 141993
27 GRAPHIC glyc-20240506xex99d2g023.jpg GRAPHIC 207288
28 GRAPHIC glyc-20240506xex99d2g024.jpg GRAPHIC 188906
29 GRAPHIC glyc-20240506xex99d2g025.jpg GRAPHIC 200596
30 GRAPHIC glyc-20240506xex99d2g026.jpg GRAPHIC 180936
31 GRAPHIC glyc-20240506xex99d2g027.jpg GRAPHIC 167254
32 GRAPHIC glyc-20240506xex99d2g028.jpg GRAPHIC 169163
33 GRAPHIC glyc-20240506xex99d2g029.jpg GRAPHIC 181261
34 GRAPHIC glyc-20240506xex99d2g030.jpg GRAPHIC 122606
35 GRAPHIC glyc-20240506xex99d2g031.jpg GRAPHIC 139425
36 GRAPHIC glyc-20240506xex99d2g032.jpg GRAPHIC 124548
  Complete submission text file 0001558370-24-006793.txt   7163597

Data Files

Seq Description Document Type Size
37 EX-101.SCH glyc-20240506.xsd EX-101.SCH 3800
38 EX-101.LAB glyc-20240506_lab.xml EX-101.LAB 1355
39 EX-101.PRE glyc-20240506_pre.xml EX-101.PRE 10724
52 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240506x8k_htm.xml XML 4612
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 24917384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)